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 Abstract 
Objective: To evaluate the longitudinal relationship between repeated measures of alcohol 
consumption and risk of developing fatty liver. 
Patients and Methods – This study includes 5,407 men and women from a British 
population based cohort, the Whitehall II study of civil servants, who self-reported alcohol 
consumption by questionnaire over approximately 30 years (1985-1989 through to 2012-
2013). Drinking typologies during midlife were linked to measures of fatty liver (the fatty 
liver index, FLI) when participants were in older age (age range 60-84 years) and adjusted for 
age, socio-economic position, ethnicity, and smoking. 
Results - Those who consistently drank heavily had two-fold higher odds of increased FLI 
compared to stable low-risk moderate drinkers after adjustment for covariates (men: 
OR=2.04, 95%CI=1.53-2.74; women: OR=2.24, 95%CI=1.08-4.55). Former drinkers also 
had an increased FLI compared to low-risk drinkers (men: OR=2.09, 95%CI=1.55-2.85; 
women: OR=1.68, 95%CI=1.08-2.67). There were non-significant differences in FLI 
between non-drinkers and stable low-risk drinkers. Among women, there was no increased 
risk for current heavy drinkers in cross sectional analyses. 
Conclusion - Drinking habits among adults during midlife affect the development of fatty 
liver and sustained heavy drinking is associated with an increased FLI compared to stable 
low-risk drinkers. After the exclusion of former drinkers, there was no difference between 
non-drinkers and low-risk drinkers, which does not support a protective effect on fatty liver 
from low-risk drinking. Cross-sectional analyses among women did not find an increased risk 
of heavy drinking compared to low-risk drinkers, thus highlighting the need to take a 
longitudinal approach.  
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 Abbreviations: UK (United Kingdom), BMI (body mass index), FLD (fatty liver disease), 
FLI (fatty liver index), SEP (socio-economic position), SD (standard deviation), OR (odds 
ratio), CI (confidence interval) 
  
 1. INTRODUCTION  
Liver disease mortality rates in UK have increased four-fold since 1970 and liver disease is 
the third most common cause of premature death in the UK (Williams et al., 2014). It has 
long been known that chronic heavy drinking is major risk factor for liver cirrhosis and liver 
cancer; approximately 20-30% of lifelong heavy drinkers develop cirrhosis (Williams et al., 
2014).  
The relationship between alcohol consumption and fatty liver disease (FLD) is less clear.  
FLD is caused by the excessive accumulation of fat in liver cells and can progress to cirrhosis 
and hepatocellular carcinoma (Reddy and Rao, 2006). The findings from a recent meta-
analysis of alcohol and risk of FLD suggest that light to moderate alcohol consumption is 
associated with a lower risk of FLD than non-drinking whilst heavy drinking is likely to be 
detrimental (Cao et al., 2016). However, most previous studies included in this meta-analysis 
were cross-sectional (15 out of 16 studies).  Taking only a single measurement of alcohol 
consumption assumes that drinking is stable over the life course which is not necessarily true 
as  data from descriptive studies indicate that people change their alcohol consumption habits 
over time (Britton et al., 2015; Kerr et al., 2002). (Greenfield and Kerr, 2011). Furthermore, 
cross-sectional studies are at risk of reverse causation whereby harm to health may have 
influenced drinking behaviour, i.e. an individual’s current drinking habits may have been 
influenced by their health rather than vice versa. The meta-analysis of observational studies 
also did not distinguish between former drinkers and never drinkers (Bell and Britton, 
2015a). Failure to include such dynamics can lead to incorrect inferences about the effects of 
alcohol on chronic disease risk (Arbeev et al., 2014).  
The “fatty liver index” (FLI), a measure that incorporates anthropometry, liver enzymes and 
metabolic parameters, has been shown to correlate with hepatic steatosis and predict fatty 
liver disease (Bedogni et al., 2006). In this paper we sought to (1) describe long term drinker 
 typologies during mid-life, (2) link these drinker typologies to risk of fatty liver disease, as 
measured by FLI in older-age and (3) compare these longitudinal associations with cross-
sectional findings in the same cohort (to contrast the associations in drinking typologies with 
associations among current drinker types). 
 
2. METHODS  
2.1 Participants and setting 
Data were drawn from a population based cohort, the Whitehall II cohort of British civil 
servants.(Marmot and Brunner, 2005)  The Whitehall II study is an on-going cohort study of 
men and women originally employed by the British civil service in London-based 
offices(Marmot and Brunner, 2005). A total of 10,308 persons (6,895 men and 3,413 women, 
aged 35 to 55 years) were recruited over the years 1985-1988.  Since baseline, there has been 
a clinical examination every 4-5 years and a self-administered questionnaire every 2 to 3 
years. Alcohol consumption was self-reported at six time points over nearly 30 years and the 
FLI was calculated when participants were in older-age (age range 60-84 years).  Data used 
in the reported analyses come from phases 1 (1985-88), 3 (1991-1994), 5 (1997-1999), 7 
(2002–2004), 9 (2007-2009) and 11 (2012-2013) of the study.  
Of the 10,308 participants at baseline, 3,990 did not participate at phase 11 (died, withdrew 
or did not respond). The analyses are based on 5,407 participants with valid FLI and repeat 
alcohol data.  We used modified Poisson regression  (Zou, 2004) to compare baseline 
characteristics of those excluded and included in the analysis, and found those included were 
more likely to be of higher socio-economic position, low-risk drinkers and never smokers. 
The University College London Medical School Committee on the ethics of human research 
approved the Whitehall II study. Written informed consent was obtained at baseline and 
renewed at each contact. Whitehall II data, protocols, and other metadata are available to 
 bona fide researchers for research purposes (data sharing policy is available at 
http://www.ucl.ac.uk/whitehallII/data-sharing).  
 
2.2 Measuring alcohol consumption 
Alcohol measurements were available at six time points over a thirty year period up to the 
measurement of the FLI. Participants were asked to report the number of alcoholic drinks 
they had consumed in the last 7 days for beer/cider (pints), wine (glasses) and spirits 
(measures) separately.  Drinks were converted into UK units of alcohol (where one unit is 
equivalent to 8g of ethanol). For phases 1 and 3 a conservative estimate was used of one UK 
unit for each measure of spirits and glass of wine, and two UK units for each pint of beer.  
From phase 5 onwards, an estimate of two units was used for each glass of wine, in 
recognition of increasing glass size and wine strength (Britton et al., 2016). These converted 
measurements were then summed to define the total weekly number of UK units consumed. 
Categories of alcohol consumption were then created based on UK guidelines for sensible 
drinking at the time of data collection (Department of Health, 1995), these were: “non-
drinker”, “former drinker”, “low-risk drinker” (within guidelines (1-14 [8-112g] units per 
week for women, 1-21 [8-168g] units per week for men)), and “heavy drinker” (above 
guidelines (15+ units for women, 22+ units for men)). Typologies of alcohol consumption 
over the six measurement periods were then created as follows: (1) “stable non-drinker” 
(consistently reported non-drinking), (2) “stable low-risk drinker”, (3) “stable heavy drinker”, 
(4) “unstable low-risk drinker” (a low-risk drinker at the majority of phases but not 
consistently so), (5) “unstable heavy drinkers” and (6) “former drinkers” (previously reported 
alcohol consumption but did not drink at the time of the last data collection phase). When an 
individual reported low-risk or heavy drinking on an equal number of occasions, participants 
 were assigned to the unstable heavy drinking group. Participants were permitted one missing 
alcohol value during follow-up (O’Neill et al., 2018). 
 
2.3 Calculating fatty liver  
FLI was used as a proxy for fatty liver disease (Bedogni et al., 2006). At phase 11 (2012-
2013), FLI was derived from measures of triglycerides, body mass index, waist 
circumference and γ-glutamyltransferase as follows: 
 
FLI = ( e0.953*loge (triglycerides)+ 0.139*BMI + 0.718*loge (GGT) + 0.053 *waist circumference – 15.745) / 
(1+e0.953*loge(triglycerides)  +  0.139* BMI + 0.718* loge (GGT) + 0.053*waist circumference - 15.745)* 100 
 
A FLI greater than or equal to 60 was considered to be high as this indicates hepatic steatosis 
as detected by ultrasonography. 
 
2.4 Covariates 
Covariates included age, sex, ethnicity, smoking status and socio-economic position (SEP). 
Smoking status (never, ex, current smoker consuming 1-10 cigarettes per days, current 
smoker of 11+ cigarettes per day) and SEP (defined using last known employment grade as 
high, intermediate and low (Britton and Marmot, 2004)) were identified from self-reported 
questionnaires completed at the time of FLI measurement. Ethnicity was categorised as white 
or non-white.  
 
2.5 Analysis 
Logistic regression was used to assess typologies of alcohol use over 30 year period and risk 
of having a FLI ≥60.  Adjustments were made for age, sex, SEP, smoking status and 
 ethnicity.  All analyses were performed in R (v3.4.1; R Foundation for Statistical Computing, 
Vienna, Austria) in 2018. Comparisons were made with cross-sectional analyses, using 
current drinker type at phase 11 (non-drinker, former drinker, current low-risk drinker, 
current heavy drinker) as the exposure and phase 11 FLI ≥60 or not as the outcome). 
Analyses were carried out in the pooled sample and separately by sex.  
There were some missing data so we performed multiple imputation (generating 100 datasets 
for both the longitudinal and cross-sectional analyses) and compared the results using 
imputation and not using imputation.  
 
3. RESULTS 
The most common alcohol typology for men was “unstable heavy” (31.1%) and “unstable 
low-risk” (30.0%) for women (Table 1). “Stable non-drinkers” were less common among 
men (3.2%) compared with women (10.2%). Higher proportions of current and ex-smokers 
were found among stable heavy drinkers. Women of high SEP were more likely to be heavy 
drinkers. The mean FLI was 47.0 (SD 27.0) for men and 36.2 (SD 29.0) for women.  
 
The association between typologies of drinking during mid-life and FLI are shown in Figure 
1. “Stable heavy” drinkers over the 30 year measurement period had higher odds of high FLI 
compared to “stable low-risk” drinkers (men: OR=2.04, 95%CI=1.53-2.74; women: 
OR=2.24, 95%CI=1.08-4.55), after adjustment for covariates.  There were no significant 
differences between “stable non-drinkers” and “stable low-risk” drinkers (men: OR=1.21, 
95%CI=0.73-1.96; women: OR=1.50, CI=0.86-2.63).  Former drinkers had increased odds of 
high FLI compared to “stable low-risk” drinkers (men: OR=2.09, 95%CI=1.55-2.85; women: 
OR=1.68, 95%CI=1.08-2.67).  
 Cross-sectional analyses among women showed no difference in odds of elevated FLI 
between current heavy drinkers and low-risk drinkers (Figure 2). However, longitudinal 
analyses showed that stable heavy drinking women had higher odds of elevated FLI 
compared to stable low-risk drinkers (Figure 1). Among both men and women, former 
drinkers had increased odds of elevated FLI compared to current low-risk drinkers (men: 
OR=1.71, 95%CI=1.37-2.15; women: OR=1.62, 95%CI=1.18-2.22). Non-drinkers (excluding 
former drinkers) did not differ to current low-risk drinkers in their odds of having an elevated 
FLI. Analyses using imputed data generated very similar results to the non-imputed findings 
(data not shown).   
 
4. DISCUSSION  
We derived 30 year drinking typologies during midlife in a large British population based 
cohort study and linked these to an indicator of fatty liver disease in early old age.  We found 
that former drinkers and those with sustained heavy drinking during midlife had greater FLI 
values than stable low-risk drinkers. We also observed that, on average, stable low-risk 
drinkers did not have reduced FLI values compared to stable non-drinkers. These findings 
converge to suggest that midlife drinking habits affect the development of fatty liver disease.  
The increased risk to health among former drinkers is found in multiple studies, most likely 
due to concurrent ill-health rather than the effect of stopping drinking (the so-called ‘sick-
quitter phenomenon’) (Shaper et al., 1988). We have previously shown that former drinkers 
in this study are a diverse group (Sabia et al., 2018) and this should not be taken as evidence 
that stopping drinking is bad for health; a more nuanced message may be required (Bell, 
2018).Our finding that stable low-risk drinking is not associated with reduced risk of fatty 
liver challenges the conclusion from a recent meta-analysis (Cao et al., 2016) (in which cross 
sectional data were used almost exclusively and former drinkers were not separated from 
 never drinkers) that reported low-risk drinking  is associated with a lower risk of fatty liver 
disease. However, our findings are in agreement with a Mendelian randomization study that 
found no evidence of beneficial effect of moderate consumption on non-alcoholic fatty liver 
disease severity. (Sookoian et al., 2016) 
We found that, among women, the risks associated with heavy drinking in mid-life were only 
appreciable when considering a longitudinal drinking typology and not in cross-sectional 
analyses. This further emphasises the necessity of taking a life course approach when 
assessing the association between alcohol consumption and health outcomes (Bell and 
Britton, 2015b; O’Neill et al., 2017). There is a serious risk of misclassification if only one 
measure of alcohol is considered. Alcohol consumption is not a stable phenomenon over the 
life course [5], as shown in this study by the large proportion of participants that did not have 
stable drinking typologies over the thirty years. Our longitudinal  work suggests that 
clinicians should consider collecting brief drinking histories as well as information on current 
intake.(Greenfield et al., 2014; Bell and Britton, 2015c) 
A major strength of this study is our ability to use repeated prospectively collected measures 
of alcohol consumption on the same individuals over three decades up to the assessment of 
FLI. The derived typologies have policy relevance as they were defined using UK 
government guidelines at the time (Department of Health, 1995). Treating FLI as a surrogate 
endpoint allowed for us to investigate how drinking during this period might set the stage for 
the development of liver disease – before it is necessarily symptomatic.  
4.1 Limitations 
Alcohol consumption was self-reported in this study and therefore at risk of misreporting 
(Bellis et al., 2015; Boniface et al., 2013). Furthermore, we were only able to capture snap 
shots of drinking over the past week and have assumed that these are a general representation 
 of levels consumed over that period,  other methods that could be used to circumvent this 
include collecting brief drinking histories (Greenfield et al., 2014). 
The study sample consists of individuals who have remained in the cohort study for three 
decades and therefore there is a risk of selective attrition (Britton and Bell, 2017; Hernán et 
al., 2004). We found those remaining in the study and attending clinical research facilities to 
be a healthier subsample than those who dropped out or who did not participate fully. 
Furthermore, occupational-based studies do not capture the extremes of drinking and 
therefore may be underpowered to look at the effects of very heavy drinking. The proportion 
of participants in this study that drink in excess of alcohol guidelines is considerably lower 
than in the general population (Health and Social Care Information Centre, 2013). In 
addition, we were unable to assess the effects of binge drinking, as these data were not 
adequately captured. It is possible that that the results from our sample may underestimate the 
risks associated with consuming alcohol if a lower proportion of the participants are binge 
drinkers compared to the general population. However, aetiological associations, such as 
those reported here, from occupational cohorts are reliable and relevant to wider populations 
(Batty et al., 2014). Although we included several covariates in the analysis, as with most 
observational studies, we cannot rule out that possibility of residual confounding. As a 
minimum we were able to adjust for smoking which is critical as heavy drinkers tend to 
smoke more than non-drinkers (Ferrence and Kozlowski, 1995). Other important behavioural 
confounders may include diet and physical activity, however our findings are concordant 
with the only Mendelian Randomisation study on this topic (Sookoian et al., 2016). 
4.2 Conclusions 
These findings indicate that the drinking habits adopted by adults during midlife affect the 
development of fatty liver, and that sustained heavy drinking is associated with an increased 
risk of poor liver health compared to stable low-risk drinking. For women, this finding was 
 not seen when only using cross-sectional analyses, thus highlighting the importance of taking 
a longitudinal approach.  Furthermore, there was no evidence of a favourable liver function 
among stable low-risk drinkers compared to non-drinkers.  
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 Table 1. Characteristics of participants by 30 year alcohol typologies in Whitehall II   
 
 
    Stable non-
drinker 
Stable low-
risk 
Stable heavy Unstable 
low-risk 
Unstable 
heavy 
Former 
drinker 
Unknown Overall 
 MEN   % 
(N)/Mean 
(SD) 
% (N)/Mean 
(SD) 
% (N)/Mean 
(SD) 
% 
(N)/Mean 
(SD) 
% 
(N)/Mean 
(SD) 
% 
(N)/Mean 
(SD) 
% 
(N)/Mean 
(SD) 
% (N)/Mean 
(SD) 
TOTAL  3.2 (124) 10.5 (411) 15.8 (621) 25.4 (995) 31.1 (1220) 12.4 (487) 1.7 (67) 100 (3925) 
FLI  39.4 (28.2) 40.3 (25.3) 52.9 (27.2) 44.1 (25.9) 48.3 (26.8) 49.5 (27.8) 51.0 (28.2) 47.0 (27.0)  
Age   69.8 (6) 69.6 (5.8) 69 (5.4) 69.6 (5.9) 69.3 (5.7) 69.4 (5.7) 67 (4.1) 69.4 (5.7) 
Ethnicity White 69.4 (86) 93.9 (386) 98.6 (612) 94 (935) 96.8 (1181) 90.1 (439) 95.5 (64) 94.3 (3703) 
  Non-white 30.6 (38) 5.8 (24) 1.3 (8) 5.9 (59) 3.1 (38) 9.9 (48) 4.5 (3) 5.6 (218) 
Smoking Non-smoker 58.1 (72) 53.3 (219) 27.1 (168) 47.3 (471) 38.3 (467) 42.5 (207) 10.4 (7) 41 (1611) 
  Ex-smoker 32.3 (40) 39.9 (164) 65.2 (405) 46.2 (460) 55.6 (678) 45.6 (222) 58.2 (39) 51.2 (2008) 
  Current 0-10 1.6 (2) 0.7 (3) 1.4 (9) 1 (10) 1.6 (20) 1 (5) 1.5 (1) 1.3 (50) 
  Current 11+ 1.6 (2) 1.5 (6) 2.9 (18) 1.3 (13) 1.1 (14) 1.8 (9) 3 (2) 1.6 (64) 
SEP Low 10.5 (13) 2.9 (12) 0.8 (5) 4.2 (42) 1.7 (21) 7.6 (37) 7.5 (5) 3.4 (135) 
  Medium 54 (67) 41.4 (170) 31.6 (196) 40.9 (407) 33.1 (404) 51.3 (250) 40.3 (27) 38.8 (1521) 
  High 35.5 (44) 55.7 (229) 67.6 (420) 54.9 (546) 65.2 (795) 41.1 (200) 52.2 (35) 57.8 (2269) 
          
WOMEN           
TOTAL  10.2 (151) 12.3 (183) 3.7 (55) 30.0 (444) 18.7 (277) 23.8 (352) 1.3 (20) 100 (1482) 
FLI  41.9 (31.7) 31.3 (25.6) 45.9 (31.7) 35.3 (28.3) 29.8 (27.5) 40.8 (29.6) 39.4 (27.7) 36.2 (29.0)  
Age   70.9 (6.2) 69.4 (6) 67.6 (5.4) 69.3 (6) 68.4 (5.4) 70.9 (5.8) 67.3 (5.4) 69.6 (5.9) 
Ethnicity White 58.3 (88) 94 (172) 100 (55) 89.9 (399) 98.6 (273) 83.5 (294) 95 (19) 87.7 (1300) 
  Non-white 41.1 (62) 6 (11) 0 (0) 9.9 (44) 1.4 (4) 16.5 (58) 5 (1) 12.1 (180) 
Smoking Non-smoker 63.6 (96) 62.3 (114) 38.2 (21) 51.8 (230) 36.8 (102) 52 (183) 25 (5) 50.7 (751) 
  Ex-smoker 17.9 (27) 30.1 (55) 47.3 (26) 40.5 (180) 54.9 (152) 33.5 (118) 45 (9) 38.3 (567) 
  Current 0-10 3.3 (5) 1.1 (2) 1.8 (1) 1.1 (5) 2.9 (8) 1.1 (4) 0 (0) 1.7 (25) 
  Current 11+ 2 (3) 1.1 (2) 0 (0) 1.4 (6) 2.9 (8) 3.1 (11) 0 (0) 2 (30) 
SEP Low 45 (68) 15.3 (28) 0 (0) 24.1 (107) 7.6 (21) 35.8 (126) 40 (8) 24.2 (358) 
  Medium 45 (68) 55.2 (101) 36.4 (20) 50 (222) 44.4 (123) 50.6 (178) 35 (7) 48.5 (719) 
  High 9.9 (15) 29.5 (54) 63.6 (35) 25.9 (115) 48 (133) 13.6 (48) 25 (5) 27.3 (405) 
 
  
Figure 1. 30 year typologies of alcohol consumption and odds of high FLI (reference group: stable low-risk drinkers). Adjusted for age, ethnicity, socio-
economic position and smoking status 
 
  
 
 
 Figure 2. Cross-sectional associations of alcohol intake and odds of high FLI (reference group: low-risk drinkers) Adjusted for age, ethnicity, socio-economic 
position and smoking status 
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